Scientists at Rutgers University–Newark have developed a first-of-its-kind RNA-based nanotechnology that assembles itself inside living human cells and can be programmed to stop propagation of harmful ...
As antibiotic-resistant infections rise and are projected to cause up to 10 million deaths per year by 2050, scientists are looking to bacteriophages, viruses that infect bacteria, as an alternative.
A machine learning algorithm used gene expression profiles of patients with gout to predict flares. The PyTorch neural network performed best, with an area under the curve of 65%. The PyTorch model ...
Using two types of harmless red-to-near-infrared light, both DNA and RNA can be distinguished simultaneously inside a cell (left), and cell aging progression can be observed (right). Early detection ...
In this tutorial, we demonstrate how to build an advanced yet accessible Bioinformatics AI Agent using Biopython and popular Python libraries, designed to run seamlessly in Google Colab. By combining ...
I am using dnbc4tools V3 beta, as I need to align against a multi-species reference. I encountered an error during dnbc4tools rna run, specifically at the oligo ...
As obesity pioneer Novo Nordisk loses ground in the race for next-generation drugs, the Danish pharma giant is betting on novel RNA technology to bolster its early-stage pipeline. Novo has inked a ...
The latest trends and issues around the use of open source software in the enterprise. JetBrains has detailed its eighth annual Python Developers Survey. This survey is conducted as a collaborative ...
A new liquid biopsy developed by researchers at the University of Chicago is offering a powerful new window into cancer’s earliest stages by flagging subtle shifts in the gut microbiome. Unlike ...
When you install Python packages into a given instance of Python, the default behavior is for the package’s files to be copied into the target installation. But sometimes you don’t want to copy the ...
Hosted on MSN
RNA Covid vaccine was initially 'developed for oncology use and was already in phase 2'
A new treatment nearly halves the risk of disease progression or death from a less common form of breast cancer that hasn't seen major drug advances in over a decade, Results from the study, presented ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results